Table 1.
miRNA | Organism | Mutation | Phenotype | Citation |
---|---|---|---|---|
Dicer1 (ribonuclease required for processing pre-miRNAs to maturity) | Zebrafish | Null | Growth arrest; death by 13–14 d.p.f | [43] |
Mouse | Null | Lethal (E7.5) | [42] | |
CKO: Nkx2.5-Cre; DicerFl/Fl | Lethal (E12.5): myocardial abnormalities, pericardial edema | [44] | ||
CKO: Nkx2.5-Cre (3'UTR-IRES-Cre); DicerFl/Fl | Lethal (E13.5): VSD, DORV, reduced OFT apoptosis | [45] | ||
CKO: Wnt1-Cre; DicerFl/Fl | Loss of sympathetic neurons; morphological defects (type B interrupted aortic arch, VSD, DORV, retroesophageal right subclavian artery, ectopic carotids) | [46,47] | ||
CKO: αMHC-Cre; DicerFl/Fl | Dilative cardiomyopathy and heart failure; death by P4 | [48] | ||
CKO: αMHC-MCM; DicerFl/Fl (3-weeks old) | Spontaneous cardiac remodeling (mild RV inflammation, atrial enlargement); sudden death by 4 weeks of age | [49] | ||
CKO: αMHC-MCM; DicerFl/Fl (adult) | Ventricular enlargement; cardiomyocyte hypertrophy and disarray; severe inflammation; interstitial ventricular fibrosis | [49] | ||
Dgcr8 (Cofactor required for cleavage of pri-miRNA hairpins) | Mouse | CKO: Wnt1-Cre; Dgcr8Fl/Fl | Persistent truncus arteriosis; VSD; interrupted aortic arch; cervical aortic arch; aberrant origin of right subclavian artery | [50] |
CKO: MCK-Cre; Dgcr8Fl/Fl | Reduced myocardial wall thickness; disrupted cardiac conduction; dilative cardiomyopathy; death by 2 months of age | [51] | ||
miR-1-1 | Mouse | Null: pGK-neomycin retained | Incompletely penetrant lethality (Sv129 background); ventricular dilation; conduction defects | [52] |
miR-1-2 | Mouse | Null: lacZ-pGK-neomycin retained | Incompletely penetrant lethality (E15.5-birth): VSD; cardiac dilation; atrial thrombosis; CM hyperplasia; conduction defects | [44] |
miR-1 | Drosophila | Null | Lethal (larval stages): Body wall collapse; striated muscle patterning defects | [53,54] |
Mouse | Null: neomycin-resistance cassettes retained | Lethal (P10): VSD, aortal misalignment; cardiac dilation; sarcomere disruption and retention of fetal sarcomere gene expression program | [52] | |
Null: neomycin-resistance cassettes excised | Lethal (P17): Dilative cardiomyopathy, CM hyperplasia; retention of fetal sarcomere gene expression program | [55] | ||
miR-133a | Mouse | Null | Incompletely penetrant lethality (P1): VSD; increased CM proliferation and ectopic smooth muscle gene expression | [56] |
miR-1/133 | Zebrafish | MO-miR-1/133 | Disrupted sarcomeric actin organization (loss of I-bands) | [57] |
Mouse | Null | Lethal (E11.5): Impaired circulation, upregulation of smooth muscle gene expression | [58] | |
miR-138 | Zebrafish | MO-miR-138 | Retention of immature CM morphology; ectopic expression of genes restricted to AVC | [59] |
miR-218 | Zebrafish | MO-miR-218 | Impaired migration of heart field progenitors; severe pericardial edema; morphological defects; ectopic expression of endothelial markers | [60,61] |
miR-92 | Zebrafish | miR-92 mimic | Cardia bifida | [62] |
MO-miR-92 | Left-right asymmetry defects | [62] | ||
miR-195 | Mouse | βMHC-miR-195 transgenic | Reduced CM proliferation; VSD; ventricular hypoplasia; dilative cardiomyopathy; premature death | [63] |
miR-17 | Mouse | miR-17 transgenic | Reduced heart weight | [64] |
miR-17~92 | Mouse | Null | Perinatally lethal: VSD | [65] |
SM22α-Cre; miR-17~92 transgenic | Cardiac hyperplasia and hypertrophy; sudden death by 2 months of age | [65] | ||
miR-17~92; miR-106b~25 | Mouse | Null | Embryonic lethal (E15): Ventricular hypoplasia, ASD, VSD, vascular congestion, edema | [66] |
miR-208a | Mouse | Null | Sarcomere structural abnormalities, arrhythmias, ectopic expression of skeletal muscle genes | [67,68] |
Abbreviations: ASD: atrial septal defect; AVC: atrioventricular canal; CM: cardiomyocyte; CKO: conditional knock-out; d.p.f.: days post-fertilization; DORV: double-outlet right ventricle; Fl/Fl: Homozygous floxed allele; MCM: Mer-Cre-Mer; MO: morpholino; OFT: outflow tract; RV: right ventricle; VSD: ventricular septal defect.